Medtronic's Stealth AXiS Surgical System Gains CE Mark Approval in Europe

Medtronic's Stealth AXiS™ Surgical System Receives CE Mark Approval

In a significant development for the healthcare sector, Medtronic, a global leader in medical technologies, has announced that its advanced Stealth AXiS™ surgical system has received the CE mark, permitting its distribution throughout Europe. This next-generation surgical platform integrates planning, navigation, and robotic assistance in a unified system, aimed at enhancing surgical outcomes in spine and cranial procedures.

The announcement, made on April 28, 2026, marks a crucial milestone in Medtronic's commitment to delivering cutting-edge surgical solutions. According to Oli Prosperi, Vice President of International Commercial, Cranial Surgical Technologies at Medtronic, ‘Receiving the CE mark for the Stealth AXiS™ system is vital for broadening access to innovative surgical technologies across Europe.’ This approval comes alongside previously secured FDA clearances, showcasing Medtronic's agility in bringing advanced healthcare technologies to the global market.

The Stealth AXiS™ system stands out for its groundbreaking integration of multiple functionalities into a single, adaptable platform. Surgeons can benefit from its LiveAlign™ segmental tracking technology, which provides real-time visibility of anatomical motion and alignment during spinal surgeries. This innovative feature enhances surgical precision and allows for more informed decision-making in the operating room.

Designed to serve various clinical workflows, the Stealth AXiS™ provides hospitals with flexibility. They can adopt essential capabilities based on their individual requirements and easily scale the system in the future. Moreover, the technology is a cornerstone of Medtronic's AiBLE™ ecosystem, which connects pre-, intra-, and post-operative processes to cultivate a coherent surgical experience.

The importance of AI in the Stealth AXiS™ system cannot be overstated. The system's AI-driven architecture enhances planning and visualization pre-, during, and post-surgery. In particular, the cranial application features AI-powered automatic tractography, enabling surgeons to create personalized brain maps and visualize critical neural pathways relevant to essential brain functions.

Michael Carter, Senior Vice President and President of Cranial Spinal Technologies at Medtronic, highlighted that the introduction of the Stealth AXiS™ system to Europe exemplifies Medtronic's dedication to providing connected platforms that boost precision, efficiency, and dependability in surgical practices. According to him, ‘By unifying planning, navigation, and robotic guidance into a single workflow, we are enabling surgeons to transform insights into actionable steps in the operating room, leading to more predictable and personalized healthcare.’

The CE mark approval further solidifies Medtronic's reputation as a leader in healthcare innovation. The company is committed to enhancing surgical standards and patient care quality through the integration of their advanced technologies. As noted by industry observers, this move will likely transform surgical procedures not only in Europe but across the globe.

For more detailed information about the Stealth AXiS™ surgical system, visit the Medtronic website and learn about how the AiBLE™ ecosystem is reshaping the landscape of surgical interventions.

Medtronic is headquartered in Galway, Ireland, and serves over four million patients each year with a diverse portfolio that includes over 150 products addressing more than 20 medical conditions. The company strives to meet the varying needs of healthcare providers and significantly improve patient care through its unwavering focus on innovation. Medtronic’s mission—to alleviate pain, restore health, and extend life—remains at the forefront of its operations, guiding its bold initiatives to tackle global healthcare challenges head-on.